Effect of moderate caloric restriction and/or weight cycling on mammary tumor incidence and latency in MMTV-Neu female mice

Nutrition and Cancer

Volumn 44, Issue 2, 2002, Pages 162-168

  Pape Ansorge, Kristin A ^a   Grande, Joseph P ^b   Christensen, Trace A ^b   Maihle, Nita J ^b   Cleary, Margot P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR ALPHA;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BREAST ADENOCARCINOMA; BREAST TUMOR; CALORIC RESTRICTION; CANCER INCIDENCE; CONTROLLED STUDY; FEMALE; FOOD INTAKE; HISTOPATHOLOGY; LUNG METASTASIS; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE NEU; REFEEDING; TRANSGENIC MOUSE; TUMOR VOLUME; ADENOCARCINOMA; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANIMAL; DISEASE MODEL; EATING; EXPERIMENTAL NEOPLASM; INCIDENCE; PHYSIOLOGY; VIRUS LATENCY;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; MURINAE; MUS MUSCULUS; ONCOVIRINAE;

ADENOCARCINOMA; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANIMALS; BODY WEIGHT; CALORIC RESTRICTION; DISEASE MODELS, ANIMAL; EATING; FEMALE; INCIDENCE; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; VIRUS LATENCY;

EID: 0347184962     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc4402_07     Document Type: Article

References (39)

1. Beth M, Berger MR, Aksoy M, and Schmahl D: Comparison between the effects of dietary fat level and calorie intake on methylnitrosourea-induced mammary carcinogenesis in female SD rats. Int J Cancer 39, 737-744, 1987.
2. Bunk B, Zhu P, Klinga K, Berger MR, and Schmahl D: Influence of reducing luxury calories in the treatment of experimental mammary carcinoma. Br J Cancer 65, 845-851, 1992.
3. Gillette CA, Zhu Z, Westerlind KC, Melby CL, Wolfe P, et al.: Energy availability and mammary carcinogenesis: effects of calorie restriction and exercise. Carcinogenesis 18, 1183-1188, 1997.
4. Klurfeld DM, Welch CB, Davis MJ, and Kritchevsky D: Determination of degree of energy restriction necessary to reduce DMBA-induced mammary tumorigenesis in rats during the promotion phase. J Nutr 119, 286-291, 1989.
5. Keenan KP, Laroque P, Ballam GC, Soper KA, Dixit R, et al.: The effects of diet, ad libitum overfeeding, and moderate dietary restriction on the rodent bioassay: the uncontrolled variable in safety assessment. Toxocol Pathol 24, 757-768, 1996.
6. Tannenbaum A: The initiation and growth of tumors. I. Effects of underfeeding. Am J Cancer 38, 335-350, 1940.
7. Tannenbaum A: The genesis and growth of tumors. II. Effects of caloric restriction per se. Cancer Res 2, 460-467, 1942.
8. Fernandes G, Chandrasekar B, Troyer DA, Venkatraman JT, and Good RA: Dietary lipids and calorie restriction affect mammary tumor incidence and gene expression in mouse mammary tumor virus/v-Ha-ras transgenic mice. Proc Natl Acad Sci USA 92, 6494-6498, 1995.
9. Engelman RW, Day NK, and Good RA: Calorie intake during mammary development influences cancer risk: lasting inhibition of C3H/HeOu mammary tumorigenesis by peripubertal calorie restriction. Cancer Res 54, 5724-5730, 1994.
10. Sarkar NH, Fernandes G, Telang NT, Kourides IA, and Good RA: Low-calorie diet prevents the development of mammary tumors in C3H mice and reduces circulating prolactin level, murine mammary tumor virus expression, and proliferation of mammary alveolar cells. Proc Natl Acad Sci USA 79, 7758-7762, 1982.
11. Tucker MJ: The effect of long-term food restriction on tumors in rodents. Int J Cancer 23, 803-807, 1979.
12. Sylvester PW, Aylsworth CF, Van Vugt DA, and Meites J: Influence of underfeeding during the "critical period" or thereafter on carcinogen-induced mammary tumors in rats. Cancer Res 42, 4943-4947, 1982.
13. Kritchevsky D, Welch CB, and Klurfeld DM: Response of mammary tumors to caloric restriction for different time periods during the promotion phase. Nutr Cancer 12, 259-269, 1989.
14. Mehta RG, Harris SR, Gunnett CA, Bunce OR, and Hartle DK: The effects of patterned calorie-restricted diets on mammary tumor incidence and plasma endothelin levels in DMBA-treated rats. Carcinogenesis 14, 1693-1696, 1993.
15. Tagliaferro AR, Ronan AM, Meeker LD, Thompson HJ, Scott AL, et al.: Cyclic food restriction alters substrate utilization and abolishes protection from mammary carcinogenesis in female rats. J Nutr 126, 1398-1405, 1996.
16. Chen R-H, Good RA, Engelman RW, Hamada N, Tanaka A, et al.: Suppression of mouse mammary tumor proviral DNA and protooncogene expression: association with nutritional regulation of mammary tumor development. Proc Natl Acad Sci USA 87, 2385-2389, 1990.
17. Carlson AJ and Hoelzel F: Apparent prolongation of the life span of rats by intermittent fasting. J Nutr 31, 363-375, 1946.
18. Cleary MP, Jacobson MK, Phillips FC, Getzin SC, Grande JP, et al.: Weight-cycling decreases incidence and increases latency of mammary tumor development to a greater extent than does chronic restriction in mouse mammary tumor virus-transforming growth factor-α mice. Cancer Epidemiol Biomarkers Prev 11, 836-843, 2002.
19. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, et al.: Expression of the neu protooncogene in mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89, 10578-10582, 1992.
20. Borg A, Tandon AK, Clark GM, Fernö M, Fugua SAW, et al.: HER-2/neu amplification predicts poor survival in node-positive breast cancer. Cancer Res 50, 4332-4337, 1990.
21. Carlomagno C, Perrone F, Gallo C, De Laurentiis M, Lauria R, et al.: c-erbB2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. J Clin Oncol 14, 2702-2708, 1996.
22. Ferrero-Poüs M, Hacène K, Bouchet C, Le Doussal V, Tubiana-Hulin M, et al.: Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis. Clin Cancer Res 6, 4745-4754, 2000.
23. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, et al.: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712, 1989.
24. Ritland SR, Rowse GJ, Chang Y, and Gendler SJ: Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice. Cancer Res 57, 3520-3525, 1997.
25. Reeves PG, Nielsen FH, and Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123, 1939-1951, 1993.
26. Cleary MP: Consequences of restricted/refeeding cycles in lean and obese female Zucker rats. J Nutr 116, 290-303, 1986.
27. Cleary MP: Response of adult lean and obese female Zucker rats to intermittent food restriction/refeeding. J Nutr 116, 1489-1499, 1986.
28. Mahler JF, Stokes W, Mann PC, Takaoka M, and Maronpot RR: Spontaneous lesions in aging FVB/N mice. Toxicol Pathol 24, 710-716, 1996.
29. Zhu Z, Haegele AD, and Thompson HJ: Effect of caloric restriction on pre-malignant and malignant stages of mammary carcinogenesis. Carcinogenesis 18, 1007-1012, 1997.
30. Sesca E, Premoselli F, Binasco V, Bollito E, and Tessitore L: Fasting-refeeding stimulates the development of mammary tumors induced by 7,12-dimethylbenz[a]anthracene. Nutr Cancer 30, 25-30, 1998.
31. Tessitore L, Chiara M, Sesca E, Premoselli F, Binasco V, et al.: Fasting during promotion, but not during initiation, enhances the growth of methylnitrosourea-induced mammary tumors. Carcinogenesis 18, 1679-1681, 1997.
32. Rowse GJ, Ritland SR, and Gendler SJ: Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis. Cancer Res 58, 2675-2679, 1998.
33. Halter SA, Dempsey PJ, Matsui S, Stokes K, Graves-Deal R, et al.: Distinctive patterns of hyperplasia in transgenic mice with mouse mammary tumor virus transforming growth factor-α. Am J Pathol 140, 1131-1146, 1992.
34. Muller WJ, Arteaga CL, Muthuswamy SK, Siegel PM, Webster MA, et al.: Synergistic interaction of the neu proto-oncogene product and transforming growth factor-α in the mammary epithelium of transgenic mice. Mol Cell Biol 16, 5726-5736, 1996.
35. Yee D, Paik S, Lebovic GS, Marcus RR, Favoni RE, et al.: Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer. Mol Endocrinol 3, 509-517, 1989.
36. Yee D: The insulin-like growth factor system as a target in breast cancer. Breast Cancer Res Treat 32, 85-95, 1998.
37. Ruggeri BA, Klurfeld DM, Kritchevsky D, and Furlanetto RW: Caloric restriction and 7,12-dimethylbenz[a]anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res 49, 4130-4134, 1989.
38. Ruggeri BA, Klurfeld DM, Kritchevsky D, and Furlanetto RW: Growth factor binding to 7,12-dimethylbenz[a]anthracene-induced mammary tumors from rats subject to chronic caloric restriction. Cancer Res 49, 4135-4241, 1989.
39. Berrigan D, Perkins SN, Haines DC, and Hursting SD: Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23, 817-822, 2002.